Início › Câncer Metastático › Geórgia
Ensaios clínicos de Câncer Metastático em Geórgia
34 estudos para Câncer Metastático estão buscando participantes em locais em Geórgia.
Cidades em Geórgia
Texto oficial do estudo (Inglês)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Emory University, Atlanta
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06465069Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Piedmont Cancer Institute, Atlanta
- Piedmont Healthcare, Atlanta
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07562152A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Winship Cancer Institute of Emory University, Atlanta
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06270706A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Emory Winship Cancer Institute, Atlanta
- Augusta University, Augusta
RecrutandoFase 1
Idades 19 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06586957Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- University Cancer & Blood Center, LLC, Athens
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07222800A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Healthcare of Atlanta - Egleston Hospital, Atlanta
RecrutandoFase 1/2
Até 25 anos · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT04094610A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- University Cancer & Blood Center, LLC, Athens
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06989437A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
- Emory Winship Cancer Institute, Atlanta
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 24 de set. de 2026 · NCT07543055A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Piedmont Columbus Regional - John B. Amos Cancer Center, Columbus
- Central Georgia Cancer Care, Macon
- City of Hope National Medical Center, Atlanta Cancer Center, Newnan
- e mais 2
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07174336A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Emory University School of Medicine - Winship Cancer Institute, Atlanta
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07114601A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Winship Cancer Institute, Emory University, Atlanta
- Nancy N. & J.C. Lewis Cancer and Research Pavillion, Savannah
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07213804Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Tennessee Oncology, PLLC- Ringgold, Ringgold
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07227415Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT04585958A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Marietta
RecrutandoFase 3
Idades de 18 a 130 · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT07647328A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University Cancer & Blood Center, LLC, Athens
- Emory University School of Medicine- Grady Campus, Atlanta
- Winship Cancer Institute, Emory University, Atlanta
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06119581AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Atlanta
RecrutandoFase 1/2
Idades de 18 a 75 · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07038343Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Winship Cancer Institute of Emory University, Atlanta
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06072612A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Emory University School of Medicine, Atlanta
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06769698FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Emory University Hospital, Atlanta
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT05614739A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
- Crinetics Study Site, Atlanta
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT07129252A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Winship Cancer Center - Emory University, Atlanta
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 15 de jul. de 2026 · NCT06657144A Study of PYX-201 in Advanced Solid Tumors
- Winship Cancer Institute, Emory University, Atlanta
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 30 de jun. de 2026 · NCT05720117A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Winship Cancer Institute, Emory University, Atlanta
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 27 de mai. de 2026 · NCT05384626A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Winship Cancer Institute at Emory University, Atlanta
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 18 de mai. de 2026 · NCT07094204Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Piedmont Healthcare, Atlanta
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 15 de mai. de 2026 · NCT05379985A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Emory University, Atlanta
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 9 de abr. de 2026 · NCT06064877A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Emory Winship Cancer Institute, Atlanta
RecrutandoFase 2/3
Todas as idades · Todos os sexos · Atualizado em 2 de abr. de 2026 · NCT06581406Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
- Emory Winship Cancer Institute, Atlanta
- Georgia Cancer Center at Augusta University, Augusta
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de abr. de 2026 · NCT05735080Venetoclax Basket Trial for High Risk Hematologic Malignancies
- Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
RecrutandoFase 1
Idades de 1 a 40 · Todos os sexos · Atualizado em 12 de mar. de 2026 · NCT05292664Collection and Storage of Tissue and Blood Samples From Patients With Cancer
- Augusta University Medical Center, Augusta
RecrutandoEstudo observacional
2 Months · Todos os sexos · Atualizado em 5 de mar. de 2026 · NCT02474160Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
- Emory Winship Cancer Institute, Atlanta
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 6 de fev. de 2026 · NCT06127407SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Atlanta
- Massive Bio SYNERGY-AI site, Savannah
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases
- Emory University Hospital/Winship Cancer Institute, Atlanta
RecrutandoFase 1 inicial
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2025 · NCT06328686A Beta-only IL-2 ImmunoTherapY Study
- Emory - Winship Cancer Institute, Atlanta
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 9 de jul. de 2025 · NCT05086692Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.